Business Context and Reporting Period
Company: CytoSorbents Corporation (Nasdaq: CTSO)
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2019
Reporting Period: Quarter and three months ended March 31, 2019
This filing serves as a notification that the company issued a press release on May 7, 2019, announcing its financial results for the period ended March 31, 2019. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) but are not detailed in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended March 31, 2019.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the results but does not include the text of management commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 7, 2019) for actual revenue, net loss, and cash position figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any updated financial guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's cash runway and liquidity position as detailed in the full report.